Alliance Pharma PLC Annual Report and AGM Notice (5309L)
April 19 2018 - 12:25PM
UK Regulatory
TIDMAPH
RNS Number : 5309L
Alliance Pharma PLC
19 April 2018
For immediate release 19 April 2018
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Annual Report and AGM Notice
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical
company, confirms that it has today published the following
documents on its website, investors.alliancepharmaceuticals.com/,
in compliance with AIM rule 26:
-- the Annual Report for the year ended 31 December 2017
-- an explanatory circular containing the notice of the Annual
General Meeting, to be held on 24 May 2018
-- a proxy form for shareholders to vote at the AGM
Hard copies of all three documents have been posted to all
shareholders.
This announcement is released in compliance with AIM rule
20.
For further information:
Alliance Pharma plc + 44 (0) 1249 466966
John Dawson, Chief Executive Officer
Peter Butterfield, Deputy Chief Executive Officer
Andrew Franklin, Chief Financial Officer
www.alliancepharma.co.uk
Buchanan + 44 (0) 20 7466 5000
Mark Court / Sophie Wills / Gemma Mostyn-Owen
Numis Securities Limited + 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: James Black / Toby Adcock
Investec Bank plc + 44 (0) 20 7597 5970
Corporate Finance: Daniel Adams / Ed Thomas
Corporate Broking: Patrick Robb / Rob Baker
Notes to editors:
About Alliance Pharma
Alliance, founded in 1998, is an international specialty
pharmaceutical group based in Chippenham, Wiltshire, UK. The Group
has sales in more than 100 countries worldwide via direct sales,
joint ventures and a wide network of distributors. Alliance has a
strong track record of acquiring the rights to established niche
products and it currently owns or licenses the rights to
approximately 90 pharmaceutical and consumer healthcare products.
The Group continues to explore opportunities to expand its product
portfolio.
Alliance joined the AIM market of the London Stock Exchange in
December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCZMGMDVLZGRZM
(END) Dow Jones Newswires
April 19, 2018 12:25 ET (16:25 GMT)
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alliance Pharma (LSE:APH)
Historical Stock Chart
From Apr 2023 to Apr 2024